// App-Quantinova.ai

3148 : Clinical validation of a next-generation sequencing assay specifically for blood-drop liquid biopsy

Researchers

Presenter

  • Chen-Hsiung Yeh

Principal Investigators

  • Jonathan Spurgin

  • Andrew Ford

  • John Athanasuleas

  • Upender Manne

Medical Centers

  • Circulogene Theranostics, Homewood, AL

  • Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Plasma cell-free DNA

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A